All Stories

  1. Future Opportunities in Malaria Management Offered by Probiotics

    Article • Infectious Disorders - Drug Targets, August 2024, Bentham Science Publishers

    ROHIT BHATIA, Aman deep

  2. The Re-emergence of Diphtheria Amidst Multiple Outbreaks in Nigeria

    Article • Infectious Disorders - Drug Targets, June 2024, Bentham Science Publishers

    Aman deep, Okesanya Olalekan John

  3. Biopharmaceuticals: Challenges and Opportunities in Formulation and Delivery

    Article • Current Pharmaceutical Design, June 2024, Bentham Science Publishers

    Ankit Awasthi, Aman deep, Raj Kamal

  4. Managing indian pharmaceutical supply chain.

    Article • Infectious Disorders - Drug Targets, May 2024, Bentham Science Publishers

    Aman deep, Animesh ranjan

  5. Hand, Foot, and Mouth Disease Outbreak What You Need to Know

    Article • Infectious Disorders - Drug Targets, November 2023, Bentham Science Publishers

    Okesanya Olalekan John , Aman deep

  6. The resurgence of H3N2 in India: is it life-threatening?

    Article • Current Drug Targets, September 2023, Bentham Science Publishers

    Aman deep, Sonakshi Garg, Gurisha Garg

  7. Fluorescence Resonance Energy Transfer (FRET) based Sensors: An Advanced Multifactorial Approach in Modern Analysis

    Article • Current Pharmaceutical Design, August 2023, Bentham Science Publishers

    ROHIT BHATIA, Aman deep

  8. Impact of Coumarin Hybrids upon Imperative Clinical Targets against Cancer

    Article • September 2022, Bentham Science Publishers

    ROHIT BHATIA, Aman deep, Dr Ravindra K Rawal

  9. Fundamentals of Nanocarriers and Probiotics in the Treatment of Cervical Cancer

    Article • Current Nanomedicine, December 2020, Bentham Science Publishers

    Aman deep, Dr Sankha Bhattacharya

  10. Nanoparticles as budding trends in colon drug delivery for the management of ulcerative colitis

    Article • Current Nanomedicine, June 2020, Bentham Science Publishers

    Aman deep, Dr Uttam Kumar Mandal

  11. Spray dried formulation of mesalamine embedded with probiotic biomass for the treatment of ulcerative colitis: in-vitro and in-vivo studies

    Article • Drug Development and Industrial Pharmacy, September 2019, Taylor & Francis

    Aman deep, NEERAJ MISHRA